Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Mol Cell Endocrinol ; 524: 111170, 2021 03 15.
Artículo en Inglés | MEDLINE | ID: mdl-33482284

RESUMEN

Accumulating evidence indicates the association between changes in circulating sex steroid hormone levels and the development of diabetic nephropathy. However, the renal synthesis of steroid hormones during diabetes is essentially unknown. Male Wistar rats were injected with streptozotocin (STZ) or vehicle. After one week, no changes in functional or structural parameters related to kidney damage were observed in STZ group; however, a higher renal expression of proinflammatory cytokines and HSP70 was found. Expression of Steroidogenic Acute Regulatory protein (StAR) and P450scc (CYP11A1) was decreased in STZ kidneys. Incubation of isolated mitochondria with 22R-hydroxycholesterol revealed a marked inhibition in CYP11A1 function at the medullary level in STZ group. The inhibition of these first steps of renal steroidogenesis in early STZ-induced diabetes led to a decreased local synthesis of pregnenolone and progesterone. These findings stimulate investigation of the probable role of nephrosteroids in kidney damage associated with diabetes.


Asunto(s)
Diabetes Mellitus/metabolismo , Diabetes Mellitus/patología , Riñón/metabolismo , Riñón/patología , Esteroides/biosíntesis , Animales , Glucemia/metabolismo , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Enzima de Desdoblamiento de la Cadena Lateral del Colesterol/genética , Enzima de Desdoblamiento de la Cadena Lateral del Colesterol/metabolismo , Citocinas/genética , Citocinas/metabolismo , Diabetes Mellitus/sangre , Diabetes Mellitus/genética , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Regulación de la Expresión Génica , Proteínas HSP70 de Choque Térmico/genética , Proteínas HSP70 de Choque Térmico/metabolismo , Inflamación/patología , Mediadores de Inflamación/metabolismo , Riñón/fisiopatología , Metabolismo de los Lípidos , Masculino , Peroxidasa/metabolismo , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Pregnenolona/biosíntesis , Progesterona/sangre , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas Wistar , Receptores de GABA-A/genética , Receptores de GABA-A/metabolismo , Estreptozocina , Testosterona/sangre
2.
Can J Physiol Pharmacol ; 96(4): 366-371, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29120676

RESUMEN

Acetaminophen (APAP) is a widely prescribed analgesic and antipyretic drug. In the present work, we studied the effects of glutamine (Gln) in an in vivo model of APAP-induced nephrotoxicity in male Wistar rats. Renal function, histological characteristics, and Na+,K+-ATPase cortical abundance and distribution were analyzed. The appearance of HSP70 and actin in urine was also evaluated. Myeloperoxidase (MPO) activity in cortical tissue was measured as an index of the inflammatory response. Gln administration 30 min before APAP protected from the renal functional and histological damage promoted by APAP. Rats that received the dual treatment Gln and APAP (Gln/APAP) showed the same level of Na+,K+-ATPase cortical induction as APAP-treated animals, but the enzyme maintained its normal basolateral localization. HSP70 abundance was increased up to the same level in the Gln, APAP, and Gln/APAP groups. Urinary HSP70 and actin were detected only in the APAP-treated animals, reinforcing the protection of renal tubular integrity afforded by the Gln pretreatment. Gln pretreatment also protected from the increment in MPO activity promoted by APAP. Our results support the idea that Gln pretreatment could be a therapeutic option to prevent APAP-induced renal injury.


Asunto(s)
Acetaminofén/efectos adversos , Glutamina/uso terapéutico , Enfermedades Renales/inducido químicamente , Enfermedades Renales/tratamiento farmacológico , Sustancias Protectoras/uso terapéutico , Actinas/metabolismo , Animales , Modelos Animales de Enfermedad , Glutamina/farmacología , Proteínas HSP70 de Choque Térmico/metabolismo , Proteínas HSP70 de Choque Térmico/orina , Riñón/efectos de los fármacos , Riñón/patología , Riñón/fisiopatología , Enfermedades Renales/patología , Enfermedades Renales/fisiopatología , Masculino , Peroxidasa/metabolismo , Sustancias Protectoras/farmacología , Transporte de Proteínas/efectos de los fármacos , Ratas Wistar , ATPasa Intercambiadora de Sodio-Potasio/metabolismo
4.
Pediatr Nephrol ; 25(7): 1245-53, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20352459

RESUMEN

Acetaminophen (APAP) is an analgesic-antipyretic drug widely used in children. In the present study, we used an in vivo model of APAP-induced nephrotoxicity in male Wistar rats. We analyzed whether toxic doses of APAP could induce heat shock protein 70 (HSP70) in the kidney and whether HSP70 could be detected in urine. Renal function and histological evaluation of the kidneys were performed at different times after APAP administration (1,000 mg/kg body weight i.p.). Cellular injury was assessed by Triton X-100 solubilization of Na(+)/K(+) ATPase. Renal and hepatic glutathione levels were also measured. Urinary N-acetyl-beta-D glucosaminidase (NAG) excretion increased 4 h after intoxication. At this time, urea and creatinine were at control levels and a slight degree of histological alteration was detected. Kidney microscopic evaluation, Na(+)/K(+) ATPase solubility, creatinine, and urea levels and NAG excretion did not differ from those of controls 48 h after APAP administration. HSP70 was detected in urine obtained from 4 to 24 h after APAP administration. HSP70 abundance in renal cortex was increased at early time points and 48 h after APAP administration. Urinary HSP70 excretion would be a marker of its renal induction combined with the loss of tubule integrity. NAG would be a suitable early biomarker of APAP-induced nephrotoxicity.


Asunto(s)
Acetaminofén/toxicidad , Analgésicos no Narcóticos/toxicidad , Proteínas HSP70 de Choque Térmico/biosíntesis , Enfermedades Renales/metabolismo , Acetilglucosaminidasa/orina , Animales , Creatinina/sangre , Modelos Animales de Enfermedad , Glutatión/metabolismo , Proteínas HSP70 de Choque Térmico/orina , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Enfermedades Renales/inducido químicamente , Enfermedades Renales/patología , Pruebas de Función Renal , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratas , Ratas Wistar , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Urea/sangre
5.
Nephron Exp Nephrol ; 112(1): e10-9, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19342869

RESUMEN

BACKGROUND/AIMS: Contributions to the understanding of acute renal failure (ARF) pathogenesis have not been translated into an effective clinical therapy. We studied the effects of pretreatment with the angiotensin II type 1 (AT1) receptor blocker, losartan, on renal function, tissue injury, inflammatory response and serum aldosterone levels in a model of ischemic ARF. METHODS: Rats underwent unilateral renal ischemia followed by 24 h of reperfusion (IR), and were pretreated or not with 8 (IRL8) or 80 (IRL80) mg/kg/day of losartan for 3 days. RESULTS: IR kidneys showed marked renal dysfunction, epithelial damage, capillary congestion, increased myeloperoxidase (MPO) activity and increased TNF-alpha, IL1-beta and IL-6 mRNA levels. IRL80 kidneys showed protection against dysfunction and tissue injury, associated with normal MPO activity and cytokine mRNA levels. The lower dose was not able to achieve the same degree of functional renoprotection and could not prevent an increase of MPO or proinflammatory cytokine mRNA levels. The high losartan dose completely prevented an increase of serum aldosterone levels induced by IR. CONCLUSION: Renoprotection of the high losartan dose would be mainly mediated by its anti-inflammatory actions. Our results show a potential pathophysiological role of AT1 activation in promoting renal dysfunction, structural injury, inflammation and aldosterone elevation after IR injury.


Asunto(s)
Lesión Renal Aguda/etiología , Lesión Renal Aguda/prevención & control , Bloqueadores del Receptor Tipo 1 de Angiotensina II/uso terapéutico , Riñón/irrigación sanguínea , Losartán/uso terapéutico , Receptor de Angiotensina Tipo 1/fisiología , Daño por Reperfusión/complicaciones , Daño por Reperfusión/prevención & control , Enfermedad Aguda , Animales , Riñón/efectos de los fármacos , Riñón/patología , Masculino , Ratas , Ratas Wistar
6.
Biochim Biophys Acta ; 1740(3): 332-9, 2005 Jun 10.
Artículo en Inglés | MEDLINE | ID: mdl-15949700

RESUMEN

In previous works we reported that the administration of a toxic dose of acetaminophen (APAP) induces acute renal failure (ARF) and promotes changes on Na(+), K(+)ATPase distribution in renal proximal plasma membranes. In the present work, we analyzed if APAP could promote the dissociation of Na(+), K(+)ATPase from its membrane anchorage. The participation of calpain activation was also evaluated. We analyzed the Triton X-100 extractability of Na(+), K(+)ATPase in freshly isolated cortical cell suspensions incubated with different APAP concentrations (0.1, 1, 10 and 100 mM). Both alpha(1) and beta(1) subunits were studied by Western blot. APAP promoted the increment of both subunits abundance in the Triton-soluble fraction. Calpain activation was detected in the membrane fractions of cells incubated with APAP. Incubation with APAP 0.1, 1 and 10 mM did not promote an increment in LDH release compared with controls, while APAP 100 mM promoted an increased LDH release. Our results show that incubation of proximal cells with sublethal and lethal APAP concentrations promotes the detachment of Na(+), K(+)ATPase from its membrane anchoring. Inhibition of calpain activation by SJA 7029 protected against APAP-induced membrane damage but not against APAP-induced increase of the Triton X-100 extractability of Na(+), K(+)ATPase.


Asunto(s)
Acetaminofén/toxicidad , Membrana Celular/efectos de los fármacos , Túbulos Renales Proximales/efectos de los fármacos , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Animales , Western Blotting , Calpaína/antagonistas & inhibidores , Calpaína/metabolismo , Membrana Celular/metabolismo , Relación Dosis-Respuesta a Droga , Túbulos Renales Proximales/citología , Túbulos Renales Proximales/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Masculino , Octoxinol , Ratas , Ratas Wistar
7.
Eur J Pharmacol ; 449(1-2): 155-8, 2002 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-12163119

RESUMEN

The effects of the central-type benzodiazepine receptor antagonist flumazenil on renal vascular tone and its ability to reverse the benzodiazepine-induced vasodilation were investigated. The isolated and perfused rat kidney model was used. Flumazenil was unable to modify renal vascular resistance under basal conditions and in noradrenaline-pretreated kidneys. Relaxation induced by diazepam or clonazepam of noradrenaline-preconstricted renal vasculature was blunted by 10 microM flumazenil. These results suggest that central-type benzodiazepine receptors could be involved in benzodiazepine-induced renal vasodilation.


Asunto(s)
Diazepam/antagonistas & inhibidores , Flumazenil/farmacología , Moduladores del GABA/farmacología , Relajantes Musculares Centrales/antagonistas & inhibidores , Músculo Liso Vascular/efectos de los fármacos , Circulación Renal/efectos de los fármacos , Animales , Clonazepam/farmacología , Diazepam/farmacología , Masculino , Relajantes Musculares Centrales/farmacología , Relajación Muscular/efectos de los fármacos , Norepinefrina/farmacología , Ratas , Ratas Wistar , Vasoconstrictores/farmacología
8.
Ren Fail ; 24(2): 111-26, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12071586

RESUMEN

The purpose of this study was to assess the effects of the cyclooxygenase inhibitor, indomethacin, and some vasoactive agents on the renal functional parameters during the early liver injury induced by four days bile duct ligation (BDL). Wistar rats with four days-BDL and control-sham operated were used. Renal function was measured in anesthetized rat treated with a single dose of indomethacin (control, 0.3, 1.0, 3.0 mg/kg b.w.; i.v.) one hour before clearance studies. Sulindac effects were also evaluated (5 mg/kg b.w., i.p). Isolated rat kidney preparations from control and BDL donor rats were used to study renal vascular response to noradrenaline, carbachol or sodium nitroprusside. The bile duct ligation promoted a diminished renal cortical plasma flow (RCPF) on the fourth day post surgery accompanied with a diminution in the glomerular filtration rate (GFR), increased filtration fraction and increased fractional excretion of water and sodium. Indomethacin 0.3 mg/kg induced an increase in GFR and RCPF, maintaining the high filtration fraction in BDL rats. The other doses did not alter these parameters as compared with bile duct ligated rats without treatment, but indomethacin 3 mg/kg caused a significant increase in filtration fraction. Indomethacin induced dose-dependent diminution in natriuresis in sham and BDL groups. Sulindac did not modify hemodynamic parameters, but induced antinatriuresis and antidiuresis in both experimental groups. Maximal vascular responses to noradrenaline measured in isolated rat kidneys were statistically diminished in BDL-rats as compared with controls (C, n=7; 35.0+/-2.3 mmHg ml(-1) min; BDL-rats, n=5; 23.8+/-0.7 mmHg ml(-1) min; p<0.02), without changes in EC15. Maximal relaxation induced by sodium nitroprusside in the phenylephrine (PHE)-pre-constricted renal vasculature in control preparations did not differ from that observed in BDL group (C: n=6; 49.5+/-2.3%). Values of EC50 were 1.26+/-0.07 microM (n=6) in control preparations and 0.34+/-0.03 microM (n=4) in kidneys from BDL-rats (p<0.001). Carbachol induced a biphasic relaxation of PHE-pre-constricted renal vasculature. No differences in maximal responses were found. EC50 value of the second phase in BDL group was significantly decreased compared to control preparations (C: n=6, 0.47+/-0.05 microM; BDL: n=6, 0.22+/-0.03 microM p<0.001). The present results show that the altered renal function after a short time post bile duct ligation is determined, at least in part, by increased release of arachidonic derivatives in vascular bed and tubular cells. At this stage of liver injury, the alteration in the renal vascular response to different vasoactive agents is remarkable.


Asunto(s)
Conductos Biliares/fisiopatología , Conductos Biliares/cirugía , Inhibidores de la Ciclooxigenasa/farmacología , Indometacina/farmacología , Riñón/efectos de los fármacos , Riñón/fisiopatología , Hígado/lesiones , Hígado/fisiopatología , Vasoconstrictores/farmacología , Animales , Conductos Biliares/efectos de los fármacos , Modelos Animales de Enfermedad , Tasa de Filtración Glomerular/efectos de los fármacos , Tasa de Filtración Glomerular/fisiología , Ligadura/efectos adversos , Hígado/efectos de los fármacos , Masculino , Ratas , Ratas Wistar , Insuficiencia Renal/etiología , Insuficiencia Renal/fisiopatología , Flujo Plasmático Renal/efectos de los fármacos , Flujo Plasmático Renal/fisiología , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...